ReviewCancer cell international2026
The possible role of sirtuins and MiRNAs in gastrointestinal cancers: special focus on Sirt1.
Review in Cancer cell international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review comprehensively examines the role of Sirtuins and microRNAs (miRNAs) in gastrointestinal cancers (GICs) with a particular focus on Sirt1. Gastrointestinal malignancies, comprising a wide range of tumors within the digestive tract, represent an essential health challenge worldwide, and are distinguished by high incidence and mortality rates. Emerging evidence implies that Sirtuins, particularly SIRT1, act as a double-edged sword in cancer biology, acting as either tumor promoters or suppressors, depending on the cellular milieu. miRNAs also have been identified as critical regulators of gene expression, impacting cancer progression through their interaction with Sirtuins. A comprehensive literature search was conducted in PubMed, Scopus, Web of Science, and Google Scholar to identify relevant studies on the topic. This review highlights the complex relationships between Sirtuins and miRNAs in GICs, exploring their potential as biomarkers for early detection and targets for therapeutic intervention. The regulatory mechanisms of miRNAs in the Sirtuin family, specifically in human GICs, are examined to identify their influence on cancer diagnosis, progression, and management. The results may ultimately serve as a basis for developing diagnostic markers for the early detection of GICs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.